TRIB
Income statement / Annual
Last year (2023), Trinity Biotech plc's total revenue was $56.83 M,
a decrease of 24.00% from the previous year.
In 2023, Trinity Biotech plc's net income was -$24.02 M.
See Trinity Biotech plc’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$56.83 M
|
$74.78 M
|
$92.97 M
|
$101.98 M
|
$90.44 M
|
$97.04 M
|
$99.14 M
|
$99.61 M
|
$100.20 M
|
$104.87 M
|
| Cost of Revenue |
$37.38 M |
$52.73 M |
$54.89 M |
$53.40 M |
$52.32 M |
$55.59 M |
$57.25 M |
$56.52 M |
$53.95 M |
$54.52 M |
| Gross Profit |
$19.45 M |
$22.05 M |
$38.08 M |
$48.58 M |
$38.12 M |
$41.45 M |
$41.89 M |
$43.09 M |
$46.25 M |
$50.35 M |
| Gross Profit Ratio |
0.34 |
0.29 |
0.41 |
0.48 |
0.42 |
0.43 |
0.42 |
0.43 |
0.46 |
0.48 |
| Research and Development
Expenses |
$4.38 M
|
$4.14 M
|
$4.50 M
|
$5.08 M
|
$5.33 M
|
$5.37 M
|
$5.66 M
|
$5.04 M
|
$5.07 M
|
$4.29 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
$28.44 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$32.25 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$31.15 M
|
$29.17 M
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
$28.44 M
|
| Other Expenses |
$10.96 M |
-$343,000.00 |
-$4.67 M |
-$1.86 M |
-$91,000.00 |
-$102,000.00 |
-$100,000.00 |
$135,000.00 |
$201,000.00 |
$252,000.00 |
| Operating Expenses |
$46.50 M |
$32.96 M |
$24.51 M |
$28.30 M |
$32.82 M |
$34.77 M |
$36.41 M |
$35.60 M |
$32.80 M |
$32.31 M |
| Cost And Expenses |
$83.88 M |
$85.69 M |
$79.40 M |
$81.70 M |
$85.13 M |
$90.35 M |
$93.66 M |
$92.12 M |
$86.75 M |
$86.83 M |
| Interest Income |
$1.17 M |
$303,000.00 |
$3,000.00 |
$36,000.00 |
$464,000.00 |
$735,000.00 |
$808,000.00 |
$2.43 M |
$12.91 M |
$96,000.00 |
| Interest Expense |
$10.15 M |
$24.75 M |
$5.46 M |
$5.54 M |
$4.95 M |
$4.39 M |
$4.68 M |
$4.73 M |
$3.48 M |
$69,000.00 |
| Depreciation &
Amortization |
$1.78 M
|
$2.33 M
|
$2.74 M
|
$3.08 M
|
$4.89 M
|
$4.12 M
|
$5.20 M
|
$5.82 M
|
$5.64 M
|
$4.50 M
|
| EBITDA |
-$24.10 M
|
-$16.71 M
|
$10.59 M
|
$21.52 M
|
-$19.52 M
|
-$13.98 M
|
-$29.27 M
|
-$30.92 M
|
$19.15 M
|
$19.93 M
|
| EBITDA Ratio |
-0.42 |
-0.11 |
0.17 |
0.22 |
0.06 |
0.08 |
0.06 |
0.1 |
0.26 |
0.17 |
| Operating Income Ratio
|
-0.48
|
-0.15
|
0.14
|
0.19
|
0.01
|
0.03
|
0.06
|
0.08
|
0.13
|
0.17
|
| Total Other
Income/Expenses Net |
-$9.88 M
|
-$24.43 M
|
-$5.86 M
|
-$6.72 M
|
-$5.89 M
|
-$2.96 M
|
-$2.21 M
|
-$2.26 M
|
$9.49 M
|
-$35,000.00
|
| Income Before Tax |
-$36.93 M |
-$41.19 M |
$751,000.00 |
-$6.63 M |
$821,000.00 |
$3.03 M |
$1.60 M |
$5.19 M |
$22.88 M |
$18.07 M |
| Income Before Tax Ratio
|
-0.65
|
-0.55
|
0.01
|
-0.07
|
0.01
|
0.03
|
0.02
|
0.05
|
0.23
|
0.17
|
| Income Tax Expense |
-$59,000.00 |
-$192,000.00 |
-$178,000.00 |
-$620,000.00 |
$4.89 M |
$637,000.00 |
-$697,000.00 |
$41,000.00 |
$1.08 M |
$853,000.00 |
| Net Income |
-$24.02 M |
-$41.00 M |
$875,000.00 |
-$6.01 M |
-$4.07 M |
$2.39 M |
-$40.27 M |
-$100.63 M |
$21.80 M |
$17.21 M |
| Net Income Ratio |
-0.42 |
-0.55 |
0.01 |
-0.06 |
-0.04 |
0.02 |
-0.41 |
-1.01 |
0.22 |
0.16 |
| EPS |
-3.14 |
-6.08 |
0.2 |
-1.44 |
-0.97 |
0.57 |
-9.31 |
-21.91 |
0.96 |
0.76 |
| EPS Diluted |
-3.14 |
-5.27 |
0.2 |
-1.44 |
-0.8 |
0.46 |
-7.49 |
-17.78 |
0.48 |
0.73 |
| Weighted Average Shares
Out |
$7.65 M
|
$6.75 M
|
$4.18 M
|
$4.18 M
|
$4.18 M
|
$4.18 M
|
$4.32 M
|
$4.59 M
|
$4.63 M
|
$4.55 M
|
| Weighted Average Shares
Out Diluted |
$7.65 M
|
$7.77 M
|
$5.33 M
|
$4.18 M
|
$5.09 M
|
$5.18 M
|
$5.38 M
|
$5.66 M
|
$5.48 M
|
$4.74 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
